Bergen Vascular Institute Launches Groundbreaking Clinical Trial on Carotid Artery Disease

Home / Bergen Vascular Institute Launches Groundbreaking Clinical Trial on Carotid Artery Disease

FOR IMMEDIATE RELEASE

Bergen Vascular Institute Launches Groundbreaking Clinical Trial on Carotid Artery Disease

Hackensack, New Jersey — Bergen Vascular Institute (BVI) is excited to announce the launch of a groundbreaking clinical trial focusing on carotid artery disease. This major initiative is part of BVI’s ongoing commitment to advancing medical research and enhancing treatment protocols through innovative health solutions.

The clinical trial, named “Carotid Care Initiative,” aims to explore and compare the effectiveness of various treatment options, including medical management, carotid artery surgery, and stenting. By doing so, BVI seeks to improve patient outcomes and set new standards in vascular care.

Dr. George Simonian, a lead surgeon at BVI, emphasized the significance of the trial: “This clinical study is a cornerstone in our pursuit to refine and enhance carotid artery disease treatment. At Bergen Vascular Institute, we are dedicated to pioneering research that leads to superior patient care and treatment options.”

BVI’s “Carotid Care Initiative” is now accepting participants, with the trial set to commence later this year. This study is expected to make significant contributions to the field of vascular medicine and patient care standards globally.

About Bergen Vascular Institute: Located in Hackensack, New Jersey, Bergen Vascular Institute is a leader in the treatment of vascular diseases, continually pushing the boundaries of medical research and clinical trials to better serve their patients and the medical community.